The World Health Organization (WHO) is working on the approval (prequalification) procedure for the Russian Sputnik V coronavirus vaccine, the Ministry of Health said.
The Russian Direct Investment Fund (RDIF) and the Gamaleya Center sent a dossier of the Sputnik V vaccine to WHO for approval for emergency use last December.
"The approval for use in emergency conditions and the subsequent prequalification of vaccines allow the supply of vaccines within the framework of UN programs, as well as facilitate access to foreign markets," the Ministry of Health explained.
The approval process is hampered by the fact that WHO experts in a pandemic do not have the physical ability to conduct face-to-face inspections of production sites. As soon as this becomes possible, a corresponding application from the Russian side will be submitted.
In addition, the department noted, the international community has not yet come to a unified decision on the recognition of vaccination with different drugs. The issue of vaccination requirements for entry and the corresponding certificates has not been resolved either. The Ministry of Health expects that all these issues will be resolved within the next few months.
“Expert consultations based on the analysis of the dossier will be held in January this year. We are awaiting the decision of the WHO in the first half of 2021, "the Russian newspaper quoted the message of the Ministry of Health.
Earlier it became known that the Minister of Health of Ukraine Maxim Stepanov confirmed the receipt of an application for registration of the Russian vaccine "Sputnik V" by the "Biolek" company.